Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study - Top-Institutions - MDSpire

Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study

  • By

  • Francesco D’Oria

  • Sara Di Giulio

  • Luciano Ibba

  • Costanza Falcidia

  • Giulio Foggi

  • Carlo Alberto Vignoli

  • Paola Facheris

  • Luigi Gargiulo

  • Ruggero Cascio Ingurgio

  • Antonio Costanzo

  • Alessandra Narcisi

  • Mario Valenti

  • July 3, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital
    Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital

    Milan, Lombardy

    Key Differentiators

    • Dermatology

  • #2

    University Hospital
    University Hospital

    Unknown, Unknown

    Key Differentiators

    • Rheumatology
    • Dermatology

Original Source(s)

Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study

  • by Francesco D’Oria, Sara Di Giulio, Luciano Ibba, Costanza Falcidia, Giulio Foggi, Carlo Alberto Vignoli, Paola Facheris, Luigi Gargiulo, Ruggero Cascio Ingurgio, Antonio Costanzo, Alessandra Narcisi, Mario Valenti

  • July 3, 2026

Related Content

Pagetoid reticulosis (Woringer–Kolopp disease) mimicking eczema: a case report with immunophenotypic analysis and literature review

Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials

Case Report: Successful topical simvastatin therapy in a 2-year-old girl with keratin 16-associated palmoplantar epidermal differentiation disorder